載入...
An In Vitro Perspective on What Individual Antimicrobials Add to Mycobacterium avium Complex Therapies
For Mycobacterium avium complex pulmonary disease (MAC-PD), current treatment regimens yield low cure rates. To obtain an evidence-based combination therapy, we assessed the in vitro activity of six drugs, namely, clarithromycin (CLR), rifampin (RIF), ethambutol (EMB), amikacin (AMK), clofazimine (C...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8284439/ https://ncbi.nlm.nih.gov/pubmed/33972258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02730-20 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|